tradingkey.logo

CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer

ReutersJun 24, 2025 12:30 PM

- Cytodyn Inc CYDY.PK:

  • CYTODYN ANNOUNCES FIRST PATIENT DOSED IN PHASE II ONCOLOGY TRIAL IN COLORECTAL CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI